Back

Evolution of cardiovascular risk factors, analytical markers and functional capacity. Are the benefits of phase II of the cardiac rehabilitation program maintained in phase III?

12 April 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention - Secondary Prevention Secondary Prevention EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Mrs Belen Garcia Magallon

Guadalajara University Hospital, Guadalajara (Spain)

30 More presentations in this session

Presentation thumbnail
Doctor J. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Doctor T. Terada (Nottingham, GB)
Abstract
Presentation thumbnail
Doctor R. Reid (Ottawa, CA)
Abstract Slides
Presentation thumbnail
Miss P. Jepma (Amsterdam, NL)
Abstract
Presentation thumbnail
Doctor J. Coelho Lima Junior (Cambridge, GB)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention - Secondary Prevention

The Event

Event poster

EuroPrevent 2019

12 April 2019 08:30 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Prevention should always follow intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources